The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Severity of bleomycin-induced lung toxicity in Indian patients with intermediate and poor-risk non-seminomatous germ cell tumors (NSGCT): A clinical perspective.
 
Himanshu Gujarathi
No Relationships to Disclose
 
Aditya Dhanawat
No Relationships to Disclose
 
Bhagyashri Jadhav
No Relationships to Disclose
 
Atul Tiwari
No Relationships to Disclose
 
Kunal Jobanputra
No Relationships to Disclose
 
Kriti YC
No Relationships to Disclose
 
Pallavi Rane
No Relationships to Disclose
 
Minit Shah
No Relationships to Disclose
 
Nandini Menon
No Relationships to Disclose
 
Priyamvada Maitre
No Relationships to Disclose
 
Mahendra Pal
No Relationships to Disclose
 
Amandeep Arora
No Relationships to Disclose
 
Aparna Ringe-Katdare
No Relationships to Disclose
 
Santosh Menon
No Relationships to Disclose
 
Gagan Prakash
No Relationships to Disclose
 
Vedang Murthy
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); NATCO Pharma (Inst); Roche (Inst)
 
Saneep Tandon
No Relationships to Disclose
 
Amit Joshi
No Relationships to Disclose